In CRC, NOTCH3 expression increases with tumor staging and is correlated with worse prognosis, poor overall survival, and CMS4 tumors, which are CAF-enriched and also associated with TGF-β signaling [58,59]. This evidence concerns the gene NOTCH3 and colorectal carcinoma.